Bifunctional Amine-Tethered Ruthenium(II) Arene Complexes Form Monofunctional Adducts on DNA
- 13 September 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 46 (21) , 8950-8962
- https://doi.org/10.1021/ic700799w
Abstract
The tethered RuII half-sandwich complexes [η6:η1-C6H5(CH2)nNH2)RuCl2] 1 (n = 3) and 2 (n = 2) have been synthesized as potential bifunctional anticancer complexes, and their X-ray crystal structures have been determined. They hydrolyze rapidly in aqueous solution to give predominantly mono-aqua mono-chlorido species. Mono-9EtG adducts, where 9EtG = 9-ethylguanine, form rapidly, but the second 9EtG binds more slowly and more weakly. In the X-ray crystal structure of the di-9EtG adduct [(η6:η1-C6H5(CH2)3NH2)Ru(9EtG)2](CF3SO3)2·H2O (8·H2O), one of the Ru−N7 bonds is significantly longer than the other (2.1588(18) vs 2.101(2) Å). The bound guanine bases adopt a head-to-head configuration, stabilized by tether NH2 hydrogen bonding to C6O of 9EtG. The X-ray crystal structure of the dinitrato complex [(η6:η1-C6H5(CH2)3NH2)Ru(NO3)2] (3) showed both nitrates to be bound to ruthenium. This complex readily rutheniated calf thymus DNA but failed to produce stop sites on pSP73KB plasmid DNA during DNA transcription by an RNA polymerase. This suggested that only monofunctional DNA adducts formed, as did interstrand cross-linking assays. Also, the unwinding angle induced in negatively supercoiled DNA (9 ± 1°) was less than that induced by cisplatin (13°). These findings may explain why complexes such as 1 and 2 exhibited low cytotoxicities (IC50 values >100 μM) toward A2780 human ovarian cancer cells.Keywords
This publication has 50 references indexed in Scilit:
- Phenylazo-pyridine and Phenylazo-pyrazole Chlorido Ruthenium(II) Arene Complexes: Arene Loss, Aquation, and Cancer Cell CytotoxicityInorganic Chemistry, 2006
- Structure−Activity Relationships for Cytotoxic Ruthenium(II) Arene Complexes Containing N,N-, N,O-, and O,O-Chelating LigandsJournal of Medicinal Chemistry, 2006
- Ruthenium(II) arene complexes containing four- and five-membered monoanionic O,O-chelate ringsInorganica Chimica Acta, 2006
- Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotideJBIC Journal of Biological Inorganic Chemistry, 2005
- Inhibition of Cancer Cell Growth by Ruthenium(II) Arene ComplexesJournal of Medicinal Chemistry, 2001
- Cationic Ruthenium Allenylidene Complexes as Catalysts for Ring Closing Olefin MetathesisChemistry – A European Journal, 2000
- Why Does Cisplatin Reach Guanine-N7 with Competing S-Donor Ligands Available in the Cell?Chemical Reviews, 1999
- Structure, Recognition, and Processing of Cisplatin−DNA AdductsChemical Reviews, 1999
- Synthesis and reactions of arene-ruthenium complexes containing nitrogen-donor ligands; Crystal structure of (p-cymene)2Ru2Cl2(N3)2Polyhedron, 1990
- Synthesis and structural characterization of η6-arene-ruthenium(II) complexes of alanine and guanine derivativesInorganica Chimica Acta, 1990